Amgen (AMGN) director Charles Holley receives 665-share RSU grant and reports 12.8K direct holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amgen Inc. director Charles M. Holley reported an equity award of 665 shares of common stock, received as a grant of Restricted Stock Units (RSUs) that vested immediately at no cash cost. The RSUs were granted under Amgen’s director incentive program and are settled one-for-one in common shares. Following this grant, Holley holds 12,799.0331 shares directly and an additional 1,260 shares indirectly through the Holley Family Trust. The direct holdings include 1,564 dividend equivalent (DE) units credited on unvested RSUs, which will convert into common shares as those RSUs vest.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
HOLLEY CHARLES M
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 665 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 12,799.033 shares (Direct, null);
Common Stock — 1,260 shares (Indirect, Holley Family Trust)
Footnotes (1)
- The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule. These shares include 1,564 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
RSU shares granted: 665 shares
Grant price per share: $0.0000 per share
Direct holdings after grant: 12,799.0331 shares
+2 more
5 metrics
RSU shares granted
665 shares
Common stock RSU award, immediate vesting on 2026-05-19
Grant price per share
$0.0000 per share
RSUs granted at no cash exercise price
Direct holdings after grant
12,799.0331 shares
Amgen common stock held directly after RSU grant
Indirect trust holdings
1,260 shares
Amgen common stock held via Holley Family Trust
Dividend equivalents
1,564 DEs
Credited to unvested RSUs, payable in shares upon vesting
Key Terms
Restricted Stock Units (RSUs), director incentive program, dividend reinvestment plan, Dividend Equivalents (DEs), +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
director incentive program financial
"granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended"
dividend reinvestment plan financial
"subject to a qualifying dividend reinvestment plan"
A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.
Dividend Equivalents (DEs) financial
"These shares include 1,564 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
deferral schedule financial
"payment will occur according to the elected deferral schedule"
FAQ
What did Amgen (AMGN) director Charles M. Holley report in this Form 4?
Charles M. Holley reported receiving 665 Amgen common shares via an immediate-vesting RSU grant. These RSUs were issued under Amgen’s director incentive program and increased his direct holdings to 12,799.0331 shares, separate from indirect shares held through the Holley Family Trust.
What are the terms of the RSU grant to Amgen (AMGN) director Charles M. Holley?
Holley received 665 RSUs that vested immediately and are paid in Amgen common stock on a one-to-one basis. The grant was made under Amgen’s 2009 Director Incentive Program, with no cash exercise price disclosed because RSUs convert directly into shares.
Can the Amgen (AMGN) RSUs granted to Charles M. Holley be deferred?
Yes. Vested RSUs may be deferred at Holley’s election, with payment in Amgen common shares occurring on a chosen deferral schedule. This allows timing of actual share delivery to be adjusted while the grant itself is already earned and vested.
What are dividend equivalents (DEs) mentioned in Charles M. Holley’s Amgen (AMGN) holdings?
The filing notes 1,564 dividend equivalents (DEs) tied to Holley’s unvested RSUs. DEs are credited in connection with dividends and are paid out as Amgen common shares on a one-for-one basis when the underlying RSUs vest, plus cash for any remaining fractional shares.
How are Holley’s indirect Amgen (AMGN) holdings structured in this Form 4?
Holley’s indirect holdings consist of 1,260 Amgen common shares held through the Holley Family Trust. This trust ownership is disclosed as indirect, distinguishing it from his 12,799.0331 directly held shares that include RSUs and associated dividend equivalents.